CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Significant Drop in Short Interest

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) saw a significant decrease in short interest in March. As of March 15th, there was short interest totalling 16,900 shares, a decrease of 54.0% from the February 28th total of 36,700 shares. Based on an average trading volume of 107,500 shares, the short-interest ratio is presently 0.2 days.

CERo Therapeutics Price Performance

CEROW stock traded down $0.00 during trading hours on Friday, reaching $0.01. 24,706 shares of the stock were exchanged, compared to its average volume of 90,403. The firm’s 50-day moving average is $0.01 and its 200-day moving average is $0.01. CERo Therapeutics has a 12 month low of $0.00 and a 12 month high of $0.13.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.